TRASYLOL 500 000 UIK/50 ml, solution for injection bottle, 50 ml
Active ingredients: APROTININE
Commercialized according to BDPMDispensing in France: Prescription only, hospital use
Solution for injectionbottle, 50 mlintraveineuse;voie extracorporelle autre
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- TRASYLOL 500 000 UIK/50 mL, solution injectable
- Pharmaceutical form
- solution injectable
- Route of administration
- intraveineuse;voie extracorporelle autre
- Presentation description
- 1 flacon(s) en verre type I de 50 mL avec bouchon bromobutyle siliconé
- Marketing authorisation holder
- NORDIC GROUP (PAYS-BAS)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 29 Jan 2018
- Prescription and dispensing conditions
- Prescription only, hospital use
- List I: prescription-only medicine
- Prescribed by specialists only
- Hospital use only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
65436166CIP75572221CIP133400955722212Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| APROTININEsolution | 500 000 UIK · un flacon de 50 mL | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.